CN108152498A - A kind of inactivation method of inspection suitable for ox BVDV, IBRV, PIV3, BRSV inactivated vaccine - Google Patents

A kind of inactivation method of inspection suitable for ox BVDV, IBRV, PIV3, BRSV inactivated vaccine Download PDF

Info

Publication number
CN108152498A
CN108152498A CN201611100655.1A CN201611100655A CN108152498A CN 108152498 A CN108152498 A CN 108152498A CN 201611100655 A CN201611100655 A CN 201611100655A CN 108152498 A CN108152498 A CN 108152498A
Authority
CN
China
Prior art keywords
cell
inactivation
virus
culture
cytopathy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201611100655.1A
Other languages
Chinese (zh)
Inventor
王炜
师新川
李真光
孟庆森
黄慧文
刘芳芳
季烨
武华
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SINOVET (JIANGSU) BIOTECHNOLOGY Co Ltd
Original Assignee
SINOVET (JIANGSU) BIOTECHNOLOGY Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SINOVET (JIANGSU) BIOTECHNOLOGY Co Ltd filed Critical SINOVET (JIANGSU) BIOTECHNOLOGY Co Ltd
Priority to CN201611100655.1A priority Critical patent/CN108152498A/en
Publication of CN108152498A publication Critical patent/CN108152498A/en
Pending legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/577Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention discloses a kind of inactivation methods of inspection suitable for ox BVDV, IBRV, PIV3, BRSV inactivated vaccine.The present invention relates to biomedicine fields, and in particular to a kind of inactivation method of inspection for being directed to bovine viral diarrhea virus, infectious bovine rhinotrachetis virus, bovine parainfluenza virus, Bovine Respiratory Syncytial viral inactivation vaccine includes the following steps:1)Virus liquid after inactivation adsorbs 40 60min on suitable cell, during which shakes 23 times;2)After absorption, the cell maintenance medium that certain volume is added in cell spinner bottle continues to cultivate, and observes cytopathy, for the virus liquid of acellular lesion, harvests cell culture fluid, and freeze thawing 23 times;3)10 15ml of the cell culture fluid after freeze thawing is taken, is inoculated on suitable cell and adsorbs, continues to cultivate.It is observed and fluoroscopic examination, such as without specificity fluorescent, then shows that inactivation is complete.Technical solution disclosed in the present invention ensure that antigen concentration and viral infection time.It examines the recall rate of virus high through the present invention inactivation method of inspection, can effectively ensure the bio-safety of inactivated vaccine.

Description

A kind of inactivation suitable for ox BVDV, IBRV, PIV3, BRSV inactivated vaccine is examined Method
Technical field
The present invention relates to biomedicine fields, and in particular to one kind is suitable for bovine viral diarrhoea(BVDV), ox infectiousness Rhinotracheitis(IBRV), bovine parainfluenza(PIV3), Bovine Respiratory Syncytial virosis(BRSV)The inactivation inspection party of inactivated vaccine Method belongs to Veterinary Medicine biological field.
Background technology
Whether vaccine immunity is the important means of prevention and control epidemic disease, survive by pathogenic microorganism in vaccine, vaccine is divided into and is gone out Live vaccine and live vaccine.Inactivated vaccine be by pathogenic microorganism chemically or physical method makes micro- life used in manufacture vaccine Activity, reproductive capacity or the pathogenicity of object disappear, but still preserve the immunogenicity of corresponding antigens.
It is one of technique important in inactivated vaccine preparation process that inactivation, which is examined, is to ensure that the important of vaccine bio-safety is arranged It applies, therefore, the effective method of inspection that inactivates has great importance to the security application of vaccine.Currently, different inactivated vaccine roots According to the characteristic of cause of disease, there is the different inactivation methods of inspection, but its it is most basic be will by it is easy, quickly determine whether to inactivate Completely, with ensure environmental organism safety, vaccine dissipate poison.
Since the characteristic of cause of disease in different inactivated vaccines is different, thus need according to the growth characteristic of cause of disease and inactivator Characteristic Design forms the different inactivation methods of inspection.For different virus, method does not have migration and applicability.For example The inactivation method of inspection of pig circular ring virus inactivated vaccine is not particularly suited for bovine viral diarrhea virus and infectious bovine rhinotrachetis The inactivation of virus is examined.
Invention content
It is suitable for bovine viral diarrhoea, infectious bovine rhinotrachetis, bovine parainfluenza, ox the purpose of the present invention is design is a kind of The inactivation method of inspection of respiratory syncytial virus (RSV) inactivated vaccine.
In order to realize the purpose, the invention discloses a kind of inactivation method of inspection, include the following steps:
1)According to needs to be detected, select suitable for bovine viral diarrhea virus, infectious bovine rhinotrachetis virus, bovine parainfluenza Or the cell line of Bovine Respiratory Syncytial virus suitable growth carries out recovery culture, wherein alternative cell line includes ox Kidney cell line(MDBK cell lines), bull testis cell(BT cell lines), nose of an ox first osteocyte system(BT cell lines), Vero cells System, BHK21 cell lines, ox primary cell, mdck cell system, cattle uterus cell line(NCL-1 cell lines), NCL-1 cell lines, rabbit Kidney primary cell(CRL-1414), rabbit kidney cell(LLC-RK1).
2)2 are selected to grow up to good cell monolayer, density discards cell training up to the rolling bottle of the appropriate volume of 80%-90% Nutrient solution takes the virus liquid 20-30ml after inactivation to be inoculated in cell spinner bottle, puts 37 DEG C, containing 5%CO2In incubator, after making inactivation Virus liquid 40-60min is adsorbed on aforementioned suitable cell, during which shake 2-3 times;
3)After absorption, the cell maintenance medium of certain volume is added in cell spinner bottle, cell spinner bottle is placed in 37 DEG C of CO2Culture After continuing culture in case 3-4 days, cytopathy is observed, for the virus liquid of acellular lesion, harvests cell culture fluid, and freeze thawing 2-3 times;
4)The cell culture fluid 10-15ml after freeze thawing is taken, is inoculated in 175cm2It is the suitable of 80%-90% that square vase, which has grown to density, On suitable cell after absorption 40-60min, nutrition maintaining liquid is added in cell spinner bottle, cell bottle is placed in 37 DEG C of CO2Incubator In continue culture 3 days, for may occur in which the virus liquid of cytopathy, observing cytopathy, such as acellular lesion, then showing to inactivate Completely;
5)For not occurring the virus liquid of cytopathy normally, culture solution is harvested, further carries out fluorescent staining.Wherein fluorescence contaminates The mode of color is:The normal virus-culturing fluid for not occurring cytopathy is taken to be inoculated in the 96 hole cell trainings for covering with individual layer suitable cell It supports in plate, per hole 0.1mL, if each 4 hole of positive-virus control wells and normal cell controls hole, is placed in 37 DEG C of CO2In incubator Continue culture 24 hours, culture solution is discarded, after cleaning 3 times with PBS, with 80% acetone and 20% methyl alcohol mixed liquor 0.1mL in -20 DEG C Fixed 30min, after cleaning 3 times with PBS, is separately added into the monoclonal antibody for particular virus of working concentration fluorescent marker 0.1mL in 37 DEG C of wet box after effect 40min, is cleaned 2 times with PBS, is placed in fluorescence microscopy Microscopic observation result.Positive-virus pair Unstressed configuration is answered according to hole and normal cell controls hole.Test hole is as without specificity fluorescent, then shown that inactivation is complete;Such as occur special Property fluorescence, then inactivation is incomplete.
Further, the cell culture fluid, the cell maintenance medium addition in cell bottle are the 1/ of cell bottle capacity 8-1/15。
Further, the cell culture fluid is the DMEM added with newborn bovine serum, fetal calf serum or horse serum Or MEM nutrient solutions;The cell maintenance medium is DMEM the or MEM nutrient solutions added with newborn bovine serum or fetal calf serum.
Further, in cell culture fluid, the additive amount of newborn bovine serum, fetal calf serum or horse serum is 5%- 10%;In cell maintenance medium, the additive amount of newborn bovine serum or fetal calf serum is 1%-3.5%.
It is worth it is specifically intended that not containing antibiotic in cell culture fluid disclosed in this invention and cell maintenance medium.
Compared to the prior art, the present invention technically has 2 important innovations:1)Inactivation inspection disclosed in this invention Proved recipe method need not dilute inactivation of viruses liquid;2)It is carried out using the monoclonal antibody of fluorescent marker inactivation inspection energy specificity, straight Sight distinguishes certain inactivation of virus situation that cell CPE does not occur.Therefore, the technical solution disclosed in the present invention not only ensure that Antigen concentration and viral infection time, and examine the recall rate of virus high through the present invention inactivation method of inspection.The present invention realizes The high accuracy that inactivation of virus is examined, can effectively improve the safety of inactivated vaccine.
Specific embodiment
The invention will now be further described with reference to specific embodiments, the advantages and features of the present invention will be with description and It is apparent.But these embodiments are only exemplary, do not form any restrictions to the scope of the present invention.People in the art Member it should be understood that without departing from the spirit and scope of the invention can to the details of technical solution of the present invention and form into Row modifications or substitutions, but these modifications and replacement are each fallen in protection scope of the present invention.
If without Special Statement, reagent employed in the present invention etc. is commercial product.
The inactivation method of inspection of 1 bovine viral diarrhea virus inactivated vaccine of embodiment
Cell and cell culture fluid:MDBK cells, cell culture fluid are the DMEM nutrient solutions containing 6% newborn bovine serum;Cell maintains Liquid is the DMEM nutrient solutions containing 3% horse serum.
1)It cultivates, the MDBK cell inoculation 3000ml rolling bottles of digestion until growing up to the good cell lists of 80%-90% 48 hours Layer, discards cell culture fluid, and the bovine viral diarrhea virus liquid 25ml of the MDBK cell culture after inactivation is taken to be inoculated in cell and is turned In bottle, 37 DEG C are put, containing 5%CO2In incubator, the virus liquid after inactivation is made to adsorb 40min on suitable cell, during which shake 2 It is secondary;
2)After absorption, the DMEM cell maintenance mediums that 175ml contains 3% horse serum are added in cell bottle, cell bottle is placed in 37 DEG C CO2Continue in incubator culture 3 days after, observe cytopathy, then show to inactivate if any cytopathy it is unqualified, for without thin The virus liquid of born of the same parents' lesion, then harvest cell culture fluid, and freeze thawing 2 times;
3)The cell culture fluid 15ml after above-mentioned freeze thawing is taken, is inoculated in 175cm2It is 80%-90%'s that square vase, which has grown to density, MDBK cells on cells after absorption 40min, the cell maintenance medium containing 3% horse serum are added in cell bottle, cell bottle is placed in 37 DEG C of CO2Continue culture 3 days in incubator.Cytopathy, such as acellular lesion are observed, then shows that inactivation is complete.For just Often do not occur the virus liquid of cytopathy, harvest culture solution, further carry out fluorescent staining.
4)The normal virus-culturing fluid for not occurring cytopathy is taken to be inoculated in the 96 hole cell trainings for covering with individual layer MDBK cells It supports in plate, per hole 0.1mL, if each 4 hole of positive-virus control wells and normal cell controls hole, is placed in 37 DEG C of CO2In incubator Continue culture 24 hours, culture solution is discarded, after being cleaned with PBS, with the 0.1mL -20 DEG C of fixations of 80% acetone and 20% methyl alcohol mixed liquor 30min after being cleaned with PBS, is separately added into the BVDV1 type monoclonal fluorescence antibody 0.1mL of 2.5 μ g/ml, is acted in 37 DEG C of wet box It after 40min, is cleaned 2 times with PBS, is placed in fluorescence microscopy Microscopic observation result.Positive-virus control wells and normal cell controls hole Answer unstressed configuration.Test hole is as without specificity fluorescent, then shown that inactivation is complete;Such as there is specificity fluorescent, then inactivation is incomplete.
The inactivation method of inspection of 2 infectious bovine rhinotrachetis cell toxicant inactivated vaccine of embodiment
Cell and cell culture fluid:MDBK cells or BT cells, cell culture fluid are the MEM nutrient solutions containing 6% newborn bovine serum; Cell maintenance medium is the MEM nutrient solutions containing 3% newborn bovine serum.
1)It cultivates, the MDBK cell inoculation 3000ml rolling bottles of digestion until growing up to the good cell lists of 80%-90% 48 hours Layer, discards cell culture fluid, and the infectious bovine rhinotrachetis virus liquid 25ml of the MDBK cell culture after inactivation is taken to be inoculated in carefully In dysuria with lower abdominal colic bottle, 37 DEG C are put, containing 5%CO2In incubator, the virus liquid after inactivation is made to adsorb 40min on suitable cell, is during which shaken It shakes 2 times;
2)After absorption, the DMEM cell maintenance mediums that 175ml contains 3% horse serum are added in cell bottle, cell bottle is placed in 37 DEG C CO2Continue in incubator culture 3 days after, observe cytopathy, then show to inactivate if any cytopathy it is unqualified, for without thin The virus liquid of born of the same parents' lesion, then harvest cell culture fluid, and freeze thawing 2 times;
3)The cell culture fluid 15ml after above-mentioned freeze thawing is taken, is inoculated in 175cm2It is 80%-90%'s that square vase, which has grown to density, MDBK cells on cells after absorption 40min, the cell maintenance medium containing 3% horse serum are added in cell bottle, cell bottle is placed in 37 DEG C of CO2Continue culture 3 days in incubator.Cytopathy, such as acellular lesion are observed, then shows that inactivation is complete.For just Often do not occur the virus liquid of cytopathy, harvest culture solution, further carry out fluorescent staining.
4)The normal virus-culturing fluid for not occurring cytopathy is taken to be inoculated in the 96 hole cell trainings for covering with individual layer MDBK cells It supports in plate, per hole 0.1mL, if each 4 hole of positive-virus control wells and normal cell controls hole, is placed in 37 DEG C of CO2In incubator Continue culture 24 hours, culture solution is discarded, after being cleaned with PBS, with the 0.1mL-20 DEG C of fixation of 80% acetone and 20% methyl alcohol mixed liquor 30min after being cleaned with PBS, is separately added into the IBRV monoclonal fluorescence antibodies 0.1mL of 2.5 μ g/ml, is acted in 37 DEG C of wet box It after 40min, is cleaned 2 times with PBS, is placed in fluorescence microscopy Microscopic observation result.Positive-virus control wells and normal cell controls hole Answer unstressed configuration.Test hole is as without specificity fluorescent, then shown that inactivation is complete;Such as there is specificity fluorescent, then inactivation is incomplete.
The inactivation method of inspection of 3 bovine parainfluenza type-3 cell toxicant inactivated vaccine of embodiment
Cell and cell culture fluid:MDBK cells or BT cells, cell culture fluid are the MEM nutrient solutions containing 6% newborn bovine serum; Cell maintenance medium is the MEM nutrient solutions containing 3% newborn bovine serum.
1)It cultivates, the MDBK cell inoculation 3000ml rolling bottles of digestion until growing up to the good cell lists of 80%-90% 48 hours Layer, discards cell culture fluid, and the infectious bovine rhinotrachetis virus liquid 25ml of the MDBK cell culture after inactivation is taken to be inoculated in carefully In dysuria with lower abdominal colic bottle, 37 DEG C are put, containing 5%CO2In incubator, the virus liquid after inactivation is made to adsorb 40min on suitable cell, is during which shaken It shakes 2 times;
2)After absorption, the DMEM cell maintenance mediums that 175ml contains 3% horse serum are added in cell bottle, cell bottle is placed in 37 DEG C CO2Continue in incubator culture 3 days after, observe cytopathy, then show to inactivate if any cytopathy it is unqualified, for without thin The virus liquid of born of the same parents' lesion, then harvest cell culture fluid, and freeze thawing 2 times;
3)The cell culture fluid 15ml after above-mentioned freeze thawing is taken, is inoculated in 175cm2It is 80%-90%'s that square vase, which has grown to density, MDBK cells on cells after absorption 40min, the cell maintenance medium containing 3% horse serum are added in cell bottle, cell bottle is placed in 37 DEG C of CO2Continue culture 3 days in incubator.Cytopathy, such as acellular lesion are observed, then shows that inactivation is complete.For just Often do not occur the virus liquid of cytopathy, harvest culture solution, further carry out fluorescent staining.
4)The normal virus-culturing fluid for not occurring cytopathy is taken to be inoculated in the 96 hole cell trainings for covering with individual layer MDBK cells It supports in plate, per hole 0.1mL, if each 4 hole of positive-virus control wells and normal cell controls hole, is placed in 37 DEG C of CO2In incubator Continue culture 24 hours, culture solution is discarded, after being cleaned with PBS, with the 0.1mL-20 DEG C of fixation of 80% acetone and 20% methyl alcohol mixed liquor 30min after being cleaned with PBS, is separately added into the PI3 monoclonal fluorescence antibodies 0.1mL of 2.5 μ g/ml, is acted in 37 DEG C of wet box After 40min, clear 2 times with PBS, it is placed in fluorescence microscopy Microscopic observation result.Positive-virus control wells and normal cell controls hole Answer unstressed configuration.Test hole is as without specificity fluorescent, then shown that inactivation is complete;Such as there is specificity fluorescent, then inactivation is incomplete.
The inactivation method of inspection of 4 Bovine Respiratory Syncytial viral inactivation vaccine of embodiment
Cell and cell culture fluid:MDBK cells or BT cells, cell culture fluid are the MEM nutrient solutions containing 6% newborn bovine serum; Cell maintenance medium is the MEM nutrient solutions containing 3% newborn bovine serum.
1)It cultivates, the MDBK cell inoculation 3000ml rolling bottles of digestion until growing up to the good cell lists of 80%-90% 48 hours Layer, discards cell culture fluid, and the infectious bovine rhinotrachetis virus liquid 25ml of the MDBK cell culture after inactivation is taken to be inoculated in carefully In dysuria with lower abdominal colic bottle, 37 DEG C are put, containing 5%CO2In incubator, the virus liquid after inactivation is made to adsorb 40min on suitable cell, is during which shaken It shakes 2 times;
2)After absorption, the DMEM cell maintenance mediums that 175ml contains 3% horse serum are added in cell bottle, cell bottle is placed in 37 DEG C CO2Continue in incubator culture 3 days after, observe cytopathy, then show to inactivate if any cytopathy it is unqualified, for without thin The virus liquid of born of the same parents' lesion, then harvest cell culture fluid, and freeze thawing 2 times;
3)The cell culture fluid 15ml after above-mentioned freeze thawing is taken, is inoculated in 175cm2It is 80%-90%'s that square vase, which has grown to density, MDBK cells on cells after absorption 40min, the cell maintenance medium containing 3% horse serum are added in cell bottle, cell bottle is placed in 37 DEG C of CO2Continue culture 3 days in incubator.Cytopathy, such as acellular lesion are observed, then shows that inactivation is complete.For just Often do not occur the virus liquid of cytopathy, harvest culture solution, further carry out fluorescent staining.
4)The normal virus-culturing fluid for not occurring cytopathy is taken to be inoculated in the 96 hole cell trainings for covering with individual layer MDBK cells It supports in plate, per hole 0.1mL, if each 4 hole of positive-virus control wells and normal cell controls hole, is placed in 37 DEG C of CO2In incubator Continue culture 24 hours, culture solution is discarded, after being cleaned with PBS, with the 0.1mL-20 DEG C of fixation of 80% acetone and 20% methyl alcohol mixed liquor 30min after being cleaned with PBS, is separately added into the BRSV monoclonal fluorescence antibodies 0.1mL of 2.5 μ g/ml, is acted in 37 DEG C of wet box It after 40min, is cleaned 2 times with PBS, is placed in fluorescence microscopy Microscopic observation result.Positive-virus control wells and normal cell controls hole Answer unstressed configuration.Test hole is as without specificity fluorescent, then shown that inactivation is complete;Such as there is specificity fluorescent, then inactivation is incomplete.

Claims (2)

1. a kind of inactivation method of inspection suitable for ox BVDV, IBRV, PI3, BRSV inactivated vaccine, it is characterized in that, including following Step:
1)Selection is suitable for bovine viral diarrhea virus and infectious bovine rhinotrachetis virus, bovine parainfluenza type-3 virus or ox breathing Road syncytial virus carries out recovery culture in the cell line of suitable growth;
2)2 are selected to grow up to good cell monolayer, density discards cell culture up to the rolling bottle of the appropriate volume of 80%-90% Liquid takes the virus liquid 20-30ml after inactivation to be inoculated in cell spinner bottle, puts 37 DEG C, containing 5%CO2In incubator, after making inactivation Virus liquid adsorbs 40-60min on aforementioned suitable cell, during which shakes 2-3 times;
3)After absorption, the cell maintenance medium of certain volume is added in cell spinner bottle, cell spinner bottle is placed in 37 DEG C of CO2Culture After continuing culture in case 3-4 days, cytopathy is observed, for the virus liquid of acellular lesion, harvests cell culture fluid, and freeze thawing 2-3 times;
4)The cell culture fluid 10-15ml after freeze thawing is taken, is inoculated in 175cm2It is the suitable of 80%-90% that square vase, which has grown to density, After adsorbing 40-60min on cell, nutrition maintaining liquid is added in cell spinner bottle, cell bottle is placed in 37 DEG C of CO2In incubator Continue culture 3 days, for may occur in which the virus liquid of cytopathy, observing cytopathy, such as acellular lesion, then showing to have inactivated Entirely;
5)For not occurring the virus liquid of cytopathy normally, culture solution is harvested, further carries out fluorescent staining, such as without special Property fluorescence, then show that inactivation is complete;Such as there is specificity fluorescent, then inactivation is incomplete.
2. the inactivation method of inspection according to claim 1 suitable for ox BVDV, IBRV, PIV3, BRSV inactivated vaccine, It is characterized in, the mode of fluorescent staining is in step 5:The normal virus-culturing fluid for not occurring cytopathy is taken to be inoculated in and covers with individual layer In 96 porocyte culture plates of MDBK cells, per hole 0.1mL, if each 4 hole of positive-virus control wells and normal cell controls hole, puts In 37 DEG C of CO2Continue culture 24 hours in incubator, discard culture solution, cleaned with PBS, mixed with 80% acetone and 20% methanol Liquid 0.1mL fixes 30min at -20 DEG C, is cleaned with PBS, and the ox for being separately added into a concentration of 2.5 μ g/ml corresponds to viral monoclonal Fluorescence antibody 0.1mL in 37 DEG C of wet box after effect 40min, is cleaned with PBS, is placed in fluorescence microscopy Microscopic observation as a result, positive disease Unstressed configuration is answered in malicious control wells and normal cell controls hole, and test hole is as without specificity fluorescent, then shown that inactivation is complete;As occurred Specificity fluorescent, then inactivation is incomplete.
CN201611100655.1A 2016-12-05 2016-12-05 A kind of inactivation method of inspection suitable for ox BVDV, IBRV, PIV3, BRSV inactivated vaccine Pending CN108152498A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201611100655.1A CN108152498A (en) 2016-12-05 2016-12-05 A kind of inactivation method of inspection suitable for ox BVDV, IBRV, PIV3, BRSV inactivated vaccine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201611100655.1A CN108152498A (en) 2016-12-05 2016-12-05 A kind of inactivation method of inspection suitable for ox BVDV, IBRV, PIV3, BRSV inactivated vaccine

Publications (1)

Publication Number Publication Date
CN108152498A true CN108152498A (en) 2018-06-12

Family

ID=62470256

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201611100655.1A Pending CN108152498A (en) 2016-12-05 2016-12-05 A kind of inactivation method of inspection suitable for ox BVDV, IBRV, PIV3, BRSV inactivated vaccine

Country Status (1)

Country Link
CN (1) CN108152498A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109593885A (en) * 2018-12-28 2019-04-09 苏州药明康德检测检验有限责任公司 Detection method that is a kind of while detecting ox source virus and pig source virus
CN115015549A (en) * 2022-07-14 2022-09-06 深圳市卫光生物制品股份有限公司 Test method for rabies vaccine inactivation verification

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103122392A (en) * 2012-11-12 2013-05-29 福州大北农生物技术有限公司 Inactivation inspection method for inactivated vaccine of porcine circovirus
CN105734007A (en) * 2016-03-10 2016-07-06 金宇保灵生物药品有限公司 Method of screening MDBK (Madin-Darby Bovine Kidney) cell lines sensitive to bovine viral diarrhea/mucosal viruses

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103122392A (en) * 2012-11-12 2013-05-29 福州大北农生物技术有限公司 Inactivation inspection method for inactivated vaccine of porcine circovirus
CN105734007A (en) * 2016-03-10 2016-07-06 金宇保灵生物药品有限公司 Method of screening MDBK (Madin-Darby Bovine Kidney) cell lines sensitive to bovine viral diarrhea/mucosal viruses

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109593885A (en) * 2018-12-28 2019-04-09 苏州药明康德检测检验有限责任公司 Detection method that is a kind of while detecting ox source virus and pig source virus
CN115015549A (en) * 2022-07-14 2022-09-06 深圳市卫光生物制品股份有限公司 Test method for rabies vaccine inactivation verification
CN115015549B (en) * 2022-07-14 2023-01-13 深圳市卫光生物制品股份有限公司 Test method for rabies vaccine inactivation verification

Similar Documents

Publication Publication Date Title
CN107201334A (en) Can be suspended the bovine kidney cells cultivated and its suspension culture method and application
CN102220287B (en) Avian infectious bronchitis cold adaptation attenuated vaccine strain and application thereof
CN101869702B (en) Vaccine produced by suspended microcarrier cell culture system and method for producing vaccine
CN110093307A (en) The method for adapting to the BHK-21-SC cell strain of serum free suspension culture and preparing vaccine antigen with the cell strain
CN106947746B (en) LDL-T plants of infectious bronchitis of chicken attenuated vaccine strain and its application
CN112779193B (en) Virulent strain of mycoplasma synoviae and application thereof
CN108042798A (en) A kind of method of suspension cell production recombinant fowl influenza virus inactivated vaccine
CN108992674A (en) A kind of heat resisting protective and its application
CN103347534A (en) Bovine viral diarrhea virus type 1b vaccine compositions and methods
CN104928260B (en) A kind of infectious bovine rhinotrachetis virus IBRV-JN03 separation strains and its application
CN101099864A (en) Method for preparing inactivated vaccine both for preventing chicken Newcastle disease and infectious bronchitis
CN106222131B (en) A kind of lamb sustentacular cell of testis nature continuous cell line and its purposes in being separately cultured and be proliferated in capripox virus
CN108152498A (en) A kind of inactivation method of inspection suitable for ox BVDV, IBRV, PIV3, BRSV inactivated vaccine
CN113122509B (en) Infectious laryngotracheitis virus virulent strain and application thereof
CN105274064B (en) A kind of duck tembusu virus attenuated vaccine strain and its application
CN107815439A (en) Infectious bovine rhinotrachetis virus JSM strains and its application
CN104056265B (en) Porcine circovirus 2 type, Porcine reproductive and respiratory syndrome bigeminy vaccine and preparation method thereof
CN108815517A (en) A kind of Duck plague live vaccine and preparation method thereof
CN105903011B (en) A kind of pseudorabies disease live-vaccine and preparation method thereof
CN105969739B (en) One plant of Akabane Disease virus vaccine strain and application thereof for being adapted to Vero cell culture
CN110302374A (en) Canine vaccine and its preparation method and application
CN102965332A (en) Swine testicular clone cell line and production method of classical swine fever live vaccine
CN112280748B (en) Sheep-derived sheep parainfluenza virus type 3 vaccine strain, vaccine composition prepared from vaccine strain, and preparation method and application of vaccine composition
CN101380470B (en) Pig parvovirus live vaccine
CN104740627B (en) A kind of large-scale method for producing of pseudo- mad dog attenuated live vaccines for animals

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20180612